Evaxion A (EVAX) Assets (2019 - 2026)
Evaxion A (EVAX) reported Assets of $23.6 million for Q1 2026, down 6.33% on a YoY basis from $25.2 million in Q1 2025, and down 16.78% quarter-over-quarter from $28.4 million in Q4 2025.
Evaxion A (EVAX) Assets (2019 - 2026) Analysis & Trends
Evaxion A has reported Assets for 8 years, with the latest figure at $23.6 million in Q1 2026.
- For the quarter ending Q1 2026, Assets fell 6.33% year-over-year to $23.6 million; the trailing twelve-month figure through Mar 2026 stood at $23.6 million (down 6.33% YoY), and the FY2025 full-year result was $28.4 million, up 127.54% from the prior year.
- Assets for Q1 2026 stood at $23.6 million, down from $28.4 million in the prior quarter.
- The five-year high for Assets was $41.1 million in Q1 2022, with the low at $22654.0 in Q1 2024.
- Historically, Assets has averaged $21.5 million across 5 years, with a median of $22.2 million in 2022.
- Annual changes were most pronounced in 2024 — Assets sank 99.89% — and 2025, when it jumped 111310.79%.
- Evaxion A's Assets stood at $22.0 million in 2022, then sank by 41.48% to $12.9 million in 2023, then fell by 3.13% to $12.5 million in 2024, then jumped by 127.54% to $28.4 million in 2025, then dropped by 16.78% to $23.6 million in 2026.
- The last three Assets figures came in at $23.6 million (Q1 2026), $28.4 million (Q4 2025), and $29.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.37 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 811.27 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 14.93 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.73 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 23.64 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 33.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 12.81 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.48 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 640.56 Mn |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 40.87 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.64 Mn |
| Dec 31, 2025 | 28.41 Mn |
| Sep 30, 2025 | 29.74 Mn |
| Jun 30, 2025 | 22.45 Mn |
| Mar 31, 2025 | 25.24 Mn |
| Dec 31, 2024 | 12.49 Mn |
| Jun 30, 2024 | 15.23 Mn |
| Mar 31, 2024 | 22,654.00 |
| Dec 31, 2023 | 12.89 Mn |
| Sep 30, 2023 | 11.94 Mn |
| Jun 30, 2023 | 16.75 Mn |
| Mar 31, 2023 | 20.49 Mn |
| Dec 31, 2022 | 22.03 Mn |
| Sep 30, 2022 | 27.45 Mn |
| Jun 30, 2022 | 34.00 Mn |
| Mar 31, 2022 | 41.08 Mn |
| Dec 31, 2021 | 40.16 Mn |
| Sep 30, 2021 | 24.12 Mn |
| Jun 30, 2021 | 27.66 Mn |
| Mar 31, 2021 | 34.92 Mn |